Skip to main content

Animations

MJFF Publications

2611 - 2620 of 8823 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2017
  • 2008
  • 2020
  • 2017
  • 2004
  • 2015
  • 2013
  • 2023
  • Summary Details
    OPEN
    Title: High-resolution local field potentials measured with deep brain stimulation arrays
    Journal Name: Journal of Neural Engineering
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1088/1741-2552/aabdf5
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27280
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies
    Journal Name: Clinica Chimica Acta
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.cca.2017.01.010
    Citation Count: 27
  • Summary Details
    RESTRICTED
    Title: Gait is associated with an increase in tonic firing of the sub-cuneiform nucleus neurons
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2008.10.046
    Citation Count: 69
  • Summary Details
    OPEN
    Title: Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease Progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28073
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12511
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.20296
    Citation Count: 389
  • Summary Details
    RESTRICTED
    Title: Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aaa3634
    Citation Count: 338
  • Summary Details
    OPEN
    Title: A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's Research
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.011940
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Longitudinal in vivo metabolic labeling reveals tissue-specific mitochondrial proteome turnover rates and proteins selectively altered by parkin deficiency
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-38484-0
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.